Lobbyist Danny Thompson, representing the Pharmaceutical Industry Labor and Management Association (PILMA), said PBMs in ...

We recently published a list of Did Jim Cramer Nail or Miss These 14 Stocks? In this article, we are going to take a look at ...

The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs ...